<DOC>
	<DOCNO>NCT00123318</DOCNO>
	<brief_summary>The purpose study determine side-effects effectiveness new type chemoradiotherapy treatment patient surgery stomach cancer . The treatment use epirubicin , cisplatin , 5-fluorouracil ( ECF ) chemotherapy together radiotherapy .</brief_summary>
	<brief_title>A Feasibility Study Evaluate Adjuvant Chemoradiotherapy Gastric Cancer</brief_title>
	<detailed_description>It show recently study conducted USA ( INT0116 ) postoperative , adjuvant chemoradiotherapy improve survival patient gastric cancer . This treatment relatively new remains debate regard optimal chemotherapy regimen optimal method radiotherapy delivery . This study evaluate new regimen adjuvant chemoradiotherapy gastric cancer employ ECF chemotherapy systemic component give concurrent chemoradiation continuous infusional 5-fluorouracil . Patients receive one cycle ECF , follow 28 day later chemoradiotherapy radiation dose 45 Gy 25 fraction 5 week , one month later two cycle ECF give . All patient treat use multiple-field conformal radiation technique . The specific objective study : - To detail acute toxicity associate treatment . - To determine feasibility propose concurrent chemoradiation regimen . - To determine feasibility standardize technique radiation treatment planning delivery . The study help develop common approach adjuvant treatment gastric cancer , require initiate clinical trial gastric cancer .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>All following must apply : Histologically proven adenocarcinoma stomach gastrooesophageal junction : 1. completely resect negative margin 2 . Stage T3,4 and/or N1,2 patient undergone D2 nodal dissection enter study discretion treat clinician . Age great equal 18 year Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 Adequate organ function define follow : Bone marrow : Haemoglobin great equal 90 g/L ; Neutrophil count great equal 1.5 x 10^9 /L ; Platelet count great equal 100 x 10^9 /L Hepatic : Serum bilirubin less equal 1.5 x ULN ; AST and/or ALT le equal 3.0 x ULN ; Renal : Serum creatinine less equal 0.150 mmol/L , calculate creatinine clearance great equal 50mL/min . Adequate oral nutrition ( intake great equal 1500 calories/day ) . This assessed dietician prior commence treatment . Disease radically treat 45 Gy standard fractionation . Patient able treat infusional 5fluorouracil ( 5FU ) ECF chemotherapy . Written informed consent None follow must apply : Evidence metastatic disease . Prior chemotherapy radiotherapy Patients significant underlying medical condition may aggravate study treatment control . Pregnant lactating female female patient childbearing potential surgically sterilize without adequate contraceptive measure . Cardiac failure ( relevant use epirubicin ) : Patients myocardial infarction within last 6 month ; Patients New York Heart Association class III/IV congestive heart failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Gastric cancer</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Chemoradiation</keyword>
</DOC>